Abstract

CRISPR-based gene editing has emerged as a revolutionary tool in pharmacology, offering unprecedented precision in manipulating the genome for therapeutic purposes. This abstract provides an in-depth exploration of recent advancements in CRISPR technology and its transformative impact on precision medicine within pharmacological research and therapy. Key topics covered include the mechanisms of CRISPR-Cas systems, applications in drug discovery and development, personalized medicine approaches, and the ethical considerations surrounding its implementation. Highlighting the potential to address genetic diseases, enhance drug efficacy, and tailor therapies to individual genetic profiles, CRISPR-based gene editing represents a cornerstone in the pursuit of more effective and personalized pharmacological interventions.